← Back to Screener
Translational Development Acquisition Corp. Units (TDACU)
Price$11.30
Growth ScoreB
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-5.15%
Price vs S&P 500 (4W)0.48%
VGM Score60.88
Market Capitalization$235.29M
P/E Ratio (Annual)36.98x
All Metrics
Book Value / Share (Quarterly)$8.05
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.03
Price vs S&P 500 (YTD)-4.09%
EPS (TTM)$0.28
10-Day Avg Trading Volume0.50M
EPS Excl Extra (TTM)$0.28
EPS (Annual)$0.29
ROI (Annual)3.63%
Cash / Share (Quarterly)$0.00
P/E Basic Excl Extra (TTM)37.88x
P/E Normalized (Annual)36.98x
ROA (Last FY)3.50%
EBITD / Share (TTM)$-0.04
Cash Flow / Share (Annual)$-0.03
P/B Ratio1.33x
P/B Ratio (Quarterly)1.31x
ROA (TTM)3.44%
EPS Growth QoQ (YoY)-10.19%
EPS Incl Extra (Annual)$0.29
Current Ratio (Annual)0.07x
Quick Ratio (Quarterly)0.03x
3-Month Avg Trading Volume0.07M
52-Week Price Return5.15%
P/E Incl Extra (TTM)37.88x
52-Week High$10.80
EPS Excl Extra (Annual)$0.29
26-Week Price Return2.78%
Quick Ratio (Annual)0.05x
13-Week Price Return1.92%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.09x
Enterprise Value$235.76M
Cash / Share (Annual)$0.00
3-Month Return Std Dev2.91%
ROE (Last FY)3.63%
EPS Basic Excl Extra (Annual)$0.29
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.28
ROI (TTM)3.56%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-29.94%
P/E Ratio (TTM)37.88x
EPS Growth TTM (YoY)342.97%
Year-to-Date Return2.38%
5-Day Price Return-0.09%
EPS Normalized (Annual)$0.29
Month-to-Date Return-0.09%
EBITD / Share (Annual)$-0.04
P/E Excl Extra (TTM)37.88x
EPS Basic Excl Extra (TTM)$0.28
P/B Ratio (Annual)1.31x
Book Value / Share (Annual)$7.99
Price vs S&P 500 (13W)-6.34%
Beta-0.20x
Revenue / Share (TTM)$0.00
ROE (TTM)3.57%
52-Week Low$10.19
gGradeB
mGradeC
vgmGradeB
Show chart for
Industry Peers — Blank Checks / SPACs(773)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TDACUTranslational Development Acquisition Corp. Units | — | B | C | $11.30 |
| KCAC.WSKensington Capital Acquisition Corp. VI Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 | F | A | A | $0.52 |
| WLACWillow Lane Acquisition Corp. Class A Ordinary Shares | — | C | A | $35.95 |
| CAEPCantor Equity Partners III, Inc. Class A Ordinary Shares | — | — | F | $6.90 |
| AACIUArmada Acquisition Corp. III Units | — | A | D | $10.08 |
| BACQRInflection Point Acquisition Corp. IV Right | — | D | D | $0.00 |
| BACQUInflection Point Acquisition Corp. IV Unit | — | D | D | $0.00 |
| AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | D | $9.95 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.08 |
| DMIIRDrugs Made In America Acquisition II Corp. Right | — | — | C | $0.08 |
| DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | C | $10.15 |
About
Translational Development Acquisition Corp is a newly formed blank check company, or special purpose acquisition vehicle (SPAC), established to identify and acquire an operating business. The company currently has no operations and is seeking to complete a business combination with a target company.